We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

62 hedge funds and large institutions have $105M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less funds holding

Funds holding: 71 → 62 (-9)

19% less capital invested

Capital invested by funds: $130M → $105M (-$25M)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

Holders
62
Holders Change
-9
Holders Change %
-12.68%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
20
Reduced
19
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$2.84M
2
CAC
Cowen and Company
New York
+$2.09M
3
KAM
Krensavage Asset Management
New York
+$1.89M
4
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
+$1.21M
5
SFO
Stokes Family Office
Louisiana
+$314K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$7.36M
2
M
Murchinson
Ontario, Canada
-$2.06M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.04M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.02M
5
Millennium Management
Millennium Management
New York
-$386K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$3K +$475 +16 +22%
Citigroup
52
Citigroup
New York
$1.83K – – –
HI
53
Harbour Investments
Wisconsin
$1.45K – – –
PGAM
54
Princeton Global Asset Management
New Jersey
$1K +$593 +20 New
GRP
55
Global Retirement Partners
California
$668 – – –
JWA
56
JFS Wealth Advisors
Pennsylvania
$610 +$534 +18 +600%
FDCDDQ
57
Federation des caisses Desjardins du Quebec
Quebec, Canada
$436 – – –
AF
58
Advisornet Financial
Minnesota
$232 +$237 +8 New
SIC
59
SJS Investment Consulting
Ohio
$174 +$59 +2 +50%
DI
60
Disciplined Investments
Oklahoma
$116 -$89 -3 -43%
AC
61
Armistice Capital
New York
– -$7.36M -245,372 Closed
Millennium Management
62
Millennium Management
New York
– -$386K -12,881 Closed
Citadel Advisors
63
Citadel Advisors
Florida
– -$343K -11,425 Closed
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
– -$275K -9,169 Closed
Goldman Sachs
65
Goldman Sachs
New York
– -$235K -7,854 Closed
CAM
66
Claret Asset Management
Quebec, Canada
– -$213K -7,119 Closed
Russell Investments Group
67
Russell Investments Group
United Kingdom
– -$9K -318 Closed
Wells Fargo
68
Wells Fargo
California
– -$4K -118 Closed
TRCT
69
Tower Research Capital (TRC)
New York
– -$3K -107 Closed
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
– -$2.7K -90 Closed
SFO
71
Standard Family Office
South Dakota
– -$2K -55 Closed
PB
72
Pinnacle Bancorp
Nebraska
– -$1K -43 Closed
AF
73
Allworth Financial
California
– -$1K -21 Closed
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
– +$59 +2 +200%
SFG
75
Steward Financial Group
Texas
– +$148 +5 New
1 2
3

TARO Hedge Fund Activity: Q4 2022 in Review

62 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2022, worth a combined $105M — down 19% from $130M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TARO and 8 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 20 added.

The largest buyer was Ameriprise, adding an estimated $2.84M. The largest seller was Armistice Capital, exiting entirely with an estimated $7.36M sold.

  • 62 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2022, down from 71 in Q3 2022.
  • Funds reported $105M of Taro Pharmaceutical Industries Ltd. stock for Q4 2022, down 19% quarter-over-quarter.
  • 8 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2022 and 15 closed out, a net change of -7 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2022 was Ameriprise, an estimated $2.84M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2022 was Armistice Capital, an estimated $7.36M sold.

Based on aggregated 13F filings for Q4 2022.